Pneumonia is a severe infectious disease. In addition to common viruses and bacterial pathogens (e.g. Streptococcus pneumoniae), fastidious respiratory pathogens like Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella spp. can cause severe atypical pneumonia. They do not respond to penicillin derivatives, which may cause failure of antibiotic empirical therapy. The same applies for infections with B. pertussis and B. parapertussis, the cause of pertussis disease, that may present atypically and need to be treated with macrolides. Moreover, these fastidious bacteria are difficult to identify by culture or serology, and therefore often remain undetected. Thus, rapid and accurate identification of bacterial pathogens causing atypical pneumonia is crucial. We performed a retrospective method evaluation study to evaluate the diagnostic performance of the new, commercially available Lightmix ® multiplex RT-PCR assay that detects these fastidious bacterial pathogens causing atypical pneumonia. In this retrospective study, 368 clinical respiratory specimens, obtained from patients suffering from atypical pneumonia that have been tested negative for the presence of common agents of pneumonia by culture and viral PCR, were investigated. These clinical specimens have been previously characterized by singleplex RT-PCR assays in our diagnostic laboratory and were used to evaluate the diagnostic performance of the respiratory multiplex Lightmix ® RT-PCR. The multiplex RT-PCR displayed a limit of detection between 5 and 10 DNA copies for different in-panel organisms and showed identical performance characteristics with respect to specificity and sensitivity as in-house singleplex RT-PCRs for pathogen detection. The Lightmix ® multiplex RT-PCR assay represents a low-cost, time-saving and accurate diagnostic tool with high throughput potential. The time-to-result using an automated DNA extraction device for respiratory specimens followed by multiplex RT-PCR detection was below 4 h, which is expected to significantly improve diagnostics for atypical pneumonia-associated bacterial pathogens.
Introduction
Community-acquired pneumonia (CAP) is a severe infectious disease. The most common causative agents include viruses (like influenza) and bacterial pathogens (like Streptococcus pneumoniae and Haemophilus influenzae) (WHO, 2016) . Besides these "common" causes of CAP, also fastidious bacterial pathogens (like Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophila and Coxiella burnetii) can cause so-called atypical pneumonia that accounts for up to 15% of all CAP cases (Cunha, 2006) . Reliable detection of agents of atypical pneumonia is crucial as they do not respond to beta-lactams (Sharma et al., 2016; Lamoth and Greub, 2010) . Therefore, empiric treatment with penicillin derivatives will be ineffective for their eradication if no additional antibiotics (e.g. macrolides) are administered to the patient (Bennett et al., 2014) . Still, the detection of atypical bacterial agents of CAP by culture or serology remains a challenge. Especially for C. pneumoniae detection, serology shows low sensitivity and insufficient specificity, making this test clinically useless (Wellinghausen et al., 2006) . Rapid and accurate molecular methods are required for fast identification of bacterial pathogens causing atypical pneumonia and to subsequently adapt the antibiotic regimen of the patients.
In this study, we present the first evaluation of the multiplex Lightmix ® RT-PCR for simultaneous detection of the most important parapertussis, Bordetella pertussis, Chlamydia pneumoniae, 1 Chlamydia psittaci, Legionella spp., Legionella pneumophila and Mycoplasma pneumoniae in clinical respiratory specimens. Among the bacterial pathogens, the majority of CAP in children and young adults is caused by M. pneumoniae resulting in mild to lifethreatening infections (Lieberman et al., 1996) . For specific multiplex RT-PCR detection, the repetitive element repMp1 was chosen as target. Compared to single-copy targets, like the P1 adhesin gene, repMp1 enables more sensitive detection of M. pneumoniae (Dumke et al., 2007) .
L. pneumophila is an opportunistic bacterial pathogen that causes severe pneumonia, especially in elderly and immunocompromised patients (Yu, 2000) . The multiplex RT-PCR targets the 16S rRNA gene and allows unambiguous differentiation of L. pneumophila from other Legionella spp. by melting curve analysis.
B. pertussis and a specific lineage of B. parapertussis infect humans, resulting in the typical symptoms of paroxysmal cough and whooping. Many countries recently reported an increase of pertussis cases, especially in infants and adolescents that are unimmunized or incompletely immunized with the pertussis vaccine (Heininger et al., 2014) . Moreover, mixed outbreaks and co-infections with B. parapertussis and B. pertussis have been reported (Zouari et al., 2012) . To maximize sensitivity, the multiplex RT-PCR targets the insertion sequences IS481 (50-100 copies per cell) and IS1001 (35-50 copies per cell) for specific detection of B. pertussis and B. parapertussis, respectively.
C. pneumoniae is an obligate intracellular pathogen that accounts for up to 10% of CAP cases and can be responsible for long-lasting disease (Kuo et al., 1995) . Although less common in recent series, C. pneumoniae still regularly causes small outbreaks (Asner et al., 2014) . Noteworthy, C. pneumoniae infection may sometimes mimic inaugural asthma (Asner et al., 2014; Webley and Hahn, 2017) and thus may remain undetected, since not tested. The multiplex RT-PCR targets the single-copy gene ompA that encodes the C. pneumoniae major outer membrane protein (MOMP) (Kuo et al., 1995) .
Atypical pneumonia may also be caused by zoonotic transmission of respiratory pathogens (e.g. Schack et al., 2014) . C. psittaci is mostly transmitted by domestic birds and causes psittacosis in humans leading to potentially life-threatening disease (Smith et al., 2011) . In addition, poultry, wild bird species and even horses have also been reported to transmit C. psittaci to humans, leading to single cases of infections or even outbreaks (Smith et al., 2011; Rehn et al., 2013; Huijskens et al., 2016) . Thus, in order to prevent underdiagnosis, the analysis of respiratory samples from patients with atypical pneumonia should include detection of C. psittaci. The multiplex RT-PCR targets the rpoB gene encoding the β-subunit of RNA polymerase that provides high taxonomic resolution and thus facilitates unambiguous C. psittaci detection (Adékambi et al., 2009) .
In this study, the diagnostic performance of the new multiplex Lightmix ® RT-PCR assay was evaluated for the detection of bacterial pathogens causing atypical pneumonia.
Materials and methods

Clinical specimens, DNA extraction and singleplex RT-PCR assays used in routine diagnostics
Respiratory clinical specimens (including sputum, bronchoalveolar lavage, respiratory swabs, tracheal and nasopharyngeal secretions) from patients with symptoms of atypical pneumonia were sent to our diagnostic laboratory for analysis (N = 355). These clinical specimens have been previously analysed by culture and viral PCR on the presence of typical agents of CAP (data not shown) and were found to be negative. We received extracted DNA from respiratory specimens (N = 13) that were tested positive for C. psittaci and C. pneumoniae, respectively from the University Hospital of Lausanne, Switzerland.
One ml of the respiratory sample was centrifuged (10 min, 14,000 rpm) and the supernatant was removed. Subsequently, 195 μl digest buffer and 5 μl proteinase K were added to the pellet and incubated on a thermomixer (2 h, 56°C, 1000 rpm). DNA from clinical specimens was extracted on the EZ1 Advanced XL (QIAGEN, Hombrechtikon, Switzerland) using the EZ1 DNA Tissue Kit (QIAGEN, Hombrechtikon, Switzerland), following the manufacturer's instructions. Respiratory pathogens were detected by singleplex in-house RT-PCR assays (SI Methods, Table S1 ). DNA from the samples was stored at −20°C for further analysis. 
Respiratory multiplex Lightmix
Analytical performance of the respiratory multiplex Lightmix ® RT-PCR
Bronchoalveolar lavage (BAL) specimens that were tested negative in the singleplex RT-PCR assays were pooled and extracted on the EZ1 Advanced XL (QIAGEN), according to the manufacturer's instructions using the EZ1 DNA Tissue Kit (QIAGEN). Analytical sensitivity for each bacterial pathogen was determined by serial dilution of the respective positive control plasmid (5-1000 DNA copies per RT-PCR reaction; Fig.  S1 ) in the BAL extracts. This allowed the generation of a standard curve and the quantification of positive samples (Fig. S1 ). The intra-run reproducibility was assessed in duplicates using the respective positive control plasmid diluted in the BAL extracts (5-1000 DNA copies per RT-PCR reaction; Fig. S2 and Table S2 ). To determine the inter-assay variability, 6 clinical respiratory samples were analysed by 3 different technicians on 3 consecutive days (Table S3) .
Performance characteristics of the respiratory multiplex RT-PCR in comparison to in-house RT-PCRs
To assess the performance of the multiplex RT-PCR, bacterial strains that are commonly found in respiratory samples or that are part of the human microbial flora and reference strains of 8 Legionella spp. were analysed, respectively (Table 2 and Table S4 ). The 8 Legionella spp. were chosen based on 16S rDNA diversity and expert opinion. Furthermore, we investigated the performance of the multiplex RT-PCR with clinical respiratory specimens that have been previously characterized by singleplex in-house RT-PCR assays (N = 368) ( Fig. 1 and Table 1 ).
Statistical methods
To determine differences in diagnostic performance of the singleplex and multiplex RT-PCR, Ƙ-statistics (Cohen, 1960 ) and the Bland and Altmann plot (Bland and Altman, 1995) were used. The inter-assay and intra-assay variability (i.e. variation coefficients) were calculated by dividing the standard deviation of the cycling threshold (Ct) values from the replicates in the multiplex RT-PCR by the mean of the Ct values from the replicates. All data analysis and data visualization was done in R (Team R, 2011) . 
Ethics
The study was conducted according to good laboratory practice and in accordance with the Declaration of Helsinki and national and institutional standards.
Results
Analytical performance of the multiplex Lightmix ® RT-PCR
The analytical sensitivity of the multiplex RT-PCR was evaluated using serial dilutions (5-1000 DNA copies per RT-PCR reaction) of the positive control plasmids in negative BAL specimens. For all respiratory pathogens analysed, the limit of detection (LOD) was determined to be between 5 and 10 DNA copies per RT-PCR reaction (Fig. S1) . The intrarun variability was assessed by plotting the Ct values of sample replicates analysed in the same RT-PCR run. The R 2 was excellent for each respiratory pathogen (i.e. R 2 ≥ 0.95) (Fig. S2) , and the variation coefficient of the intra-run variability was < 3% (Table S2 ). The inter-run variability was < 5% indicating high reproducibility of the multiplex RT-PCR results independent of the analyst performing the assay (Table  S3) .
Performance characteristics of the respiratory multiplex RT-PCR in comparison to in-house RT-PCRs
In total, 368 clinical respiratory specimens were analysed by multiplex RT-PCR. Seven samples tested positive for B. parapertussis, 170 for B. pertussis, 3 for C. pneumoniae, 11 for C. psittaci, 20 for L. pneumophila, 11 for Legionella spp. and 146 for M. pneumoniae, respectively (Table 1 and Fig. 1 ). Moreover, in two patients a co-infection of B. pertussis and B. parapertussis was observed (Fig. S3) . This underlines the good diagnostic performance of the multiplex RT-PCR, also for clinical samples with more than one bacterial pathogen present (Fig. S3) . In all 368 clinical specimens, the multiplex RT-PCR detected the same pathogen as the corresponding singleplex RT-PCR that is used in our ISO accredited diagnostic laboratory. Ƙ-statistics (Cohen, 1960) showed perfect agreement between the singleplex and the multiplex RT-PCR for the detection of all respiratory pathogens (Table 1 ). The Bland and Altman plot (Bland and Altman, 1995) showed that Ct values of the singleplex and the multiplex RT-PCR were evenly scattered above and below zero, revealing no bias of one approach versus the other (Fig. 2) . In both, the singleplex and the multiplex RT-PCR, 5 Ct values were outside the 1.96 SD of the mean (Fig. 2) .
To determine the specificity of the multiplex RT-PCR, different bacterial isolates were analysed that all tested negative, except B. holmesii that showed a positive amplification signal with the B. pertussis Lightmix ® primer/probe set ( Table 2 ). This is based on the fact that the IS481 insertion sequence is also present in some B. holmesii isolates (Pittet et al., 2014) .
Discrimination of L. pneumophila from other Legionella spp.
All Legionella spp. analysed showed a positive amplification signal in the multiplex RT-PCR and could thereby be clearly identified as positive. In melting curve analysis, all L. pneumophila serogroups showed a peak at 62°C and enabled their unambiguous differentiation from other Legionella spp. (Fig. 3 and Table S4 ). Different Legionella spp. displayed either no peak or a peak between 48°C and 55°C (Table S4) , respectively.
Discussion
We investigated the diagnostic performance of a commercial multiplex RT-PCR that targets therapeutically relevant bacterial agents of atypical pneumonia. In general, accuracy and reproducibility of the multiplex RT-PCR results were very good. Moreover, analytical sensitivity and specificity of the multiplex RT-PCR was equal to the singleplex in-house RT-PCRs that are used in our accredited diagnostics laboratory. Despite excellent specificity of the multiplex RT-PCR, we obtained one false-positive result with a sample containing B. holmesii. This owes to the fact that most PCR assays used in routine diagnostics Table 2 Bacterial strains used for determining the specificity of the multiplex Lightmix ® RT-PCR.
Species
RT-PCR Result
Corynebacterium spp.
C. trachomatis − C. abortus -for B. pertussis detection target the insertion sequence IS481 (Dalby et al., 2013) , which is also present in some B. holmesii isolates. To circumvent this problem, respiratory specimens with a positive B. pertussis amplification signal in the multiplex RT-PCR could be subjected to a second RT-PCR assay that targets genes exclusively found in B. pertussis, like the pertussis toxin gene (Sloan et al., 2002) . However, since these genes, unlike IS481, are single-copy targets, RT-PCR is less sensitive, and therefore may lead to false-negative results (Sloan et al., 2002) . The 16S rRNA gene is also not an appropriate discriminator since B. holmesii shares more than 99% sequence similarity in the 16S rRNA sequence with B. pertussis (Gross et al., 2010) . In summary, we consider the utilization of IS481as an appropriate target for the detection of B. pertussis as its high sensitivity outweighs the limitations in specificity. The multiplex RT-PCR allowed a very accurate differentiation between L. pneumophila and other, potentially apathogenic Legionella spp. Most cases of Legionnaires' disease reported are associated with L. pneumophila, especially serotype 1 (Fields et al., 2002) . This may reflect a diagnosis bias, because most commercially available kits exclusively detect L. pneumophila serotype 1 antigen in urine specimens. The Lightmix ® multiplex RT-PCR allowed identification of different L.
pneumophila serotypes and Legionella spp. Some Legionella spp. showed no T m peak in melting curve analysis. This may be explained by the fact that some Legionella spp. show basepair mismatches with the Lightmix Babady, 2013; Beckmann and Hirsch, 2016; Ozongwu et al., 2017) . However, these are mostly syndromic assays and costly, often needing test-specific equipment and consumables that are not aimed for high-throughput screening in molecular diagnostic laboratories. In addition, such test panels often include viral agents without specific therapeutic consequences. Moreover, the application of highly multiplexed assays as first-line tests in diagnostics of CAP is subject of controversial discussion (Schreckenberger and McAdam, 2015) since the mere presence of an organism does not necessarily indicate its contribution to disease. Many bacterial and viral agents with pathogenic potential in the lung may also be present in the upper respiratory tract of healthy individuals in a carriage state or may be detected after resolution of infection due to prolonged shedding (e.g. Skevaki et al., 2015; Kumar et al., 2008) . Therefore, asymptomatic carriage of viruses and bacterial pathogens (e.g. S. pneumoniae) in the upper respiratory tract poses a diagnostic problem. In contrast, no carriage of bacterial pathogens causing atypical pneumonia was found in respiratory secretions (Kumar et al., 2008) , indicating that positive test results correlate with clinical disease. However, there are also contradictory reports stating that M. pneumoniae may be carried asymptomatically in the upper respiratory tract of children (Sauteur et al., 2016) . Therefore, it is crucial to adhere to clinical case definitions and follow clinical decision rules as RT-PCR testing is unable to differentiate M. pneumoniae carriage from infection (Sauteur et al., 2016) . Our study has several limitations: It was designed as single centre laboratory-based, retrospective method evaluation study with preselected clinical specimens. The total number of samples tested positive for individual in-panel organisms like C. psittaci and C. pneumoniae is low at our institute (one positive C. pneumoniae detection in the past 5 years). In order to correct for low positive sample counts for C. psittaci and C. pneumoniae, additional samples that were tested positive at another University Hospital (CHUV, Lausanne, Switzerland) were added to the sample set. Since our study does not reflect a true epidemiology and since positive predictive values of molecular assays depend on the prevalence of in-panel organisms, clinical specimens with a positive test result for Chlamydia spp. should be confirmed by an alternative assay or send to a reference laboratory for confirmatory testing.
Conclusion
In conclusion, the multiplex Lightmix ® RT-PCR provides a reliable tool to overcome underdiagnosis of atypical pneumonia, allowing improved, targeted therapy and application of appropriate infection control measures. The multiplex Lightmix ® RT-PCR showed a good diagnostic performance that is comparable to singleplex in-house RT-PCR assays with respect to specificity and sensitivity. Moreover, the multiplex Lightmix ® RT-PCR enabled accurate detection of B. pertussis and B.
parapertussis in co-infected patients. We propose a diagnostic workflow with low per sample costs using an automated DNA extraction device (e.g. QIASymphony) and multiplex Lightmix ® RT-PCR detection. Up to 24 samples can be analysed in parallel in this workflow within less than 4 h. Therefore, it is suitable for high-throughput routine screening of multiple important respiratory pathogens causing atypical pneumonia.
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